Handle with care: Ensuring LNP lipid quality for better genetic medicines by Matthew Stone | Dec 19, 2022 | Biopharma, Blogs, ZenoTOF 7600 systemRead time: 25 min Lipid nanoparticles (LNPs) are widely used vehicles for oligonucleotide-based therapeutics and vaccines. However, LNPs can be susceptible to N-oxide-based impurities that can cause messenger RNA (mRNA) to lose function. In a recent live webinar, now...